Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-12 Schuth Alexander O. COO and Secretary Sale −800 $19.73 $16K 664,289
2019-02-12 Schuth Alexander O. COO and Secretary Sale −1,700 $20.24 $34K 662,589
2019-02-11 Schuth Alexander O. COO and Secretary Sale −1,234 $18.74 $23K 666,355
2019-02-11 Schuth Alexander O. COO and Secretary Sale −1,266 $19.35 $24K 665,089
2019-02-08 Schuth Alexander O. COO and Secretary Sale −2,500 $18.11 $45K 667,589
2019-02-08 Watts Ryan J. President and CEO Grant or award · Restricted Stock Units +11,031 11,031
2019-02-08 Watts Ryan J. President and CEO Grant or award · Restricted Stock Units +35,200 35,200
2019-02-08 Watts Ryan J. President and CEO Grant or award · Stock Option (right to buy) +281,600 281,600
2019-02-07 Schuth Alexander O. COO and Secretary Grant or award · Restricted Stock Units +17,000 17,000
2019-02-07 Schuth Alexander O. COO and Secretary Grant or award · Stock Option (right to buy) +136,000 136,000
2019-02-07 Ho Carole Chief Medical Officer Grant or award · Restricted Stock Units +17,000 17,000
2019-02-07 Ho Carole Chief Medical Officer Grant or award · Stock Option (right to buy) +136,000 136,000
2019-02-07 Krognes Steve E. CFO and Treasurer Grant or award · Restricted Stock Units +17,000 17,000
2019-02-07 Krognes Steve E. CFO and Treasurer Grant or award · Stock Option (right to buy) +136,000 136,000
2019-02-05 Ho Carole Chief Medical Officer Option exercise +7,856 $5.28 $41K 7,856
2019-02-05 Ho Carole Chief Medical Officer Sale −7,856 $18.83 $148K 0
2019-02-05 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −7,856 129,630
2019-02-05 Watts Ryan J. President and CEO Sale −8,230 $18.83 $155K 2,634,304
2019-02-04 Ho Carole Chief Medical Officer Option exercise +730 $5.28 $4K 730
2019-02-04 Ho Carole Chief Medical Officer Option exercise +3,139 $5.28 $17K 3,869

Page 43 of 53 · 1,053 trades